Autoimmune manifestations in STAG2-mutated myeloid neoplasms

Ann Hematol. 2022 Dec;101(12):2785-2787. doi: 10.1007/s00277-022-04995-5. Epub 2022 Oct 3.

Authors

Bahga Katamesh¹, Ahmad Nanaa^{1

2}, Rong He³, David Viswanatha³, Phuong Nguyen³, Patricia Greipp³, James Foran⁴, Kebede Begna¹, Naseema Gangat¹, Mrinal Patnaik¹, Ayalew Tefferi¹, Mark Litzow¹, Abhishek Mangaonkar¹, Mithun Vinod Shah¹, Talha Badar⁴, Hassan B Alkhateeb¹, Aref Al-Kali⁵

Affiliations

¹ Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
² John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 60612, USA.
³ Division of Hematopathology, Mayo Clinic, Rochester, MN, 55905, USA.
⁴ Division of Hematology, Mayo Clinic, Jacksonville, FL, 32224, USA.
⁵ Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. alkali.aref@mayo.edu.

PMID: 36184685
DOI: 10.1007/s00277-022-04995-5

No abstract available

Publication types

Letter

MeSH terms

Antigens, Nuclear / genetics
Antigens, Nuclear / metabolism
Cell Cycle Proteins / genetics
Cell Cycle Proteins / metabolism
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Humans
Mutation
Myeloproliferative Disorders*
Neoplasms*

Substances

Cell Cycle Proteins
Antigens, Nuclear
STAG2 protein, human